Suggested dosing of JT48, JTT (juzentaihoto)
Not specified
Suggested uses of JT48, JTT (juzentaihoto)
Adjunct to chemotherapy
Efficacy
Possibly effective in potentiating therapeutic effects & decreasing ADR's of antineoplastics
JT48, JTT (juzentaihoto) adverse (side) effects
None reported
Warnings
Contraindications
Hypersensitivity
Pregnancy and lactation
Pregnancy category: N/A
Lactation: N/A
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of JT48, JTT (juzentaihoto)
Metabolism: N/A
Excretion: N/A
Mechanism of action
Immunomodulatory: stim. hemopoietic factors, interleukins
